Related references
Note: Only part of the references are listed.Is obesity a prognostic factor for acute myeloid leukemia outcome?
Hun Ju Lee et al.
ANNALS OF HEMATOLOGY (2012)
Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols
Massimo Breccia et al.
BLOOD (2012)
Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia
Bruno C. Medeiros et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008
Cynthia L. Ogden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
Jeffrey E. Rubnitz et al.
LANCET ONCOLOGY (2010)
Risk-Stratified Therapy and the Intensive Use of Cytarabine Improves the Outcome in Childhood Acute Myeloid Leukemia: The AML99 Trial From the Japanese Childhood AML Cooperative Study Group
Ichiro Tsukimoto et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial
J. E. Rubnitz et al.
LEUKEMIA (2009)
Independent prognostic factors for AML outcome
D. Grimwade et al.
Hematology-American Society of Hematology Education Program (2009)
Obesity and outcome in pediatric acute lymphoblastic leukemia
Anna M. Butturini et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia
Nobuko Hijiya et al.
BLOOD (2006)
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Herbert Tilg et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Mortality in overweight and children with acute myeloid underweight leukemia
BJ Lange et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Estimates of global prevalence of childhood underweight in 1990 and 2015
M de Onis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Nutrition and the immune system from birth to old age
RK Chandra
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2002)
Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases
RA Krance et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects
MK Arnaout et al.
LEUKEMIA (2000)
Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: A report from the Children's Cancer Group study CCG-2891
AS Gamis et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)